Jim Tananbaum Investor

Jim Tananbaum is a seasoned healthcare and life sciences investor with a proven track record of success. As the Founder and CEO of Foresite Capital Management, he leads a multi-stage investment firm that focuses on funding promising healthcare businesses to address unmet clinical needs. With over a decade of experience at Prospect Venture Partners and a background in founding successful companies like Theravance and GelTex, Jim brings a unique blend of scientific expertise and business acumen to the table. His achievements include leading investments in successful healthcare startups and playing a key role in the acquisition of GelTex by Genzyme for $1.6 billion. Jim's passion for precision medicine and digital health is evident in his involvement in various industry groups and his commitment to supporting visionary entrepreneurs in the healthcare space.

Invests into